Evidence map›Paper›PMID 26566390›Full record

ArticleAIDS research and therapy2015

Community-based ART distribution system can effectively facilitate long-term program retention and low-rates of death and virologic failure in rural Uganda.

Stephen Okoboi, Erin Ding, Steven Persuad, Jonathan Wangisi, Josephine Birungi, Susan Shurgold, Darius Kato, Maureen Nyonyintono, Aggrey Egessa, Celestin Bakanda and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in AIDS research and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04766710 (Implementation and Evaluation of a Community-Based Model for Delivery of Antiretroviral Therapy in Cambodia), which is not on this map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04766710 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Implementation and Evaluation of a Community-Based Model for Delivery of Antiretroviral Therapy in Cambodia: A Quasi-Experimental Study

TypeinterventionalSponsorNational University of SingaporeRan2021 to 2024Enrolled4,102ConditionsHIV Infections, AIDSArmsCommunity-based ART delivery (CAD), ART multi-month dispensing (MMD)
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Beyond viral suppression: Quality of life among stable ART clients in a differentiated service delivery intervention in Tanzania.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Stephen OkoboiMulago Hospital Complex, The AIDS Support Organization (TASO), P.O BOX 10443, Kampala, Uganda.
Erin DingThe BC Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Steven PersuadFaculty of Medicine, University of British Columbia, Vancouver, Canada.
Jonathan WangisiMulago Hospital Complex, The AIDS Support Organization (TASO), P.O BOX 10443, Kampala, Uganda.
Josephine BirungiMulago Hospital Complex, The AIDS Support Organization (TASO), P.O BOX 10443, Kampala, Uganda.
Susan ShurgoldThe BC Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Darius KatoMulago Hospital Complex, The AIDS Support Organization (TASO), P.O BOX 10443, Kampala, Uganda.
Maureen NyonyintonoMulago Hospital Complex, The AIDS Support Organization (TASO), P.O BOX 10443, Kampala, Uganda.
Aggrey EgessaMulago Hospital Complex, The AIDS Support Organization (TASO), P.O BOX 10443, Kampala, Uganda.
Celestin BakandaMulago Hospital Complex, The AIDS Support Organization (TASO), P.O BOX 10443, Kampala, Uganda.
Paula MunderiMRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Pontiano KaleebuMRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
David M MooreThe BC Centre for Excellence in HIV/AIDS, Vancouver, Canada ; Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Mulago Hospital · UGThe AIDS Support Organization · UGAIDS Vancouver · CAUganda Virus Research Institute · UGUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCommunity-drug distribution point is a care model for stable patients in the community designed to make ART delivery more efficient for the health system and provide appropriate support to encourage long-term retention of patients. We examined program retention among ART program participants in rural Uganda, which has used a community-based distribution model of ART delivery since 2004.

methodsWe analyzed data of all patients >18 years who initiated ART in Jinja, Ugandan site of The AIDS Support Organization between January 1, 2004 and July 31, 2009. Participants attended clinic or outreach visits every 2-3 months and had CD4 cell counts measured every 6 months. Retention to care was defined as any patient with at least one visit in the 6 months before June 1, 2013. We then identified participants with at least one visit in the 6 months before June 1, 2013 and examined associations with mortality and lost-to-follow-up (LTFU). Participants with >4 years of follow up during August, 2012 to May, 2013 had viral load conducted, since no routine viral load testing was available.

resultsA total of 3345 participants began ART during 2004-2009. The median time on ART in June 2013 was 5.69 years. A total of 1335 (40 %) were residents of Jinja district and 2005 (60 %) resided in outlying districts. Of these, 2322 (69 %) were retained in care, 577 (17 %) died, 161 (5 %) transferred out and 285 (9 %) were LTFU. Factors associated with mortality or LTFU included male gender, [Adjusted Hazard Ratio (AHR) = 1.56; 95 % CI 1.28-1.9], CD4 cell count <50 cells/μL (AHR = 4.09; 95 % CI 3.13-5.36) or 50-199 cells/μL (AHR = 1.86; 95 % CI 1.46-2.37); ART initiation and WHO stages 3 (AHR = 1.35; 95 % CI 1.1-1.66) or 4 (AHR = 1.74; 95 % CI 1.23-2.45). Residence outside of Jinja district was not associated with mortality/LTFU (p value = 0.562). Of 870 participants who had VL tests, 756 (87 %) had VLs <50 copies/mL.

conclusionCommunity-based ART distribution systems can effectively mitigate the barriers to program retention and result in good rates of virologic suppression.

Indexed as

Antiretroviral therapyLost-to-follow-up; mortalityRetentionSub-Saharan AfricaUgandaVirologic failure

Identifiers

PMID26566390
PMCPMC4642676
OpenAlexW2161296045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.